title: Suppressive effect of iron on concanavalin A-induced multinucleated giant cell formation by human monocytes.
abstract: Immune dysfunction in patients with iron overload has been reported. Iron disturbed CD2 expression on T-cells, cell-mediated immunity by Th1 cells and monocyte functions including phagocytosis and natural killer activity. In the present study, we examined the effects of iron and desferrioxamine (DFX, an iron chelator) on generation of multinucleated giant cells (MGC) by human monocytes in vitro. Human monocytes were isolated from venous blood and cultured with concanavalin A (Con A) stimulation with additives, ferric citrate (Fe-citrate) or sodium citrate (Na-citrate) or DFX for 4 days. The cells were fixed and subjected to Wright staining. MGC formation was observed under light microscopy. Con A induced MGC formation in a dose-dependent manner, and reached a plateau after 3 days of incubation. MGC formation was suppressed when Con A-stimulated monocytes were cultured with the co-addition of Fe-citrate but not Na-citrate only in the early phase of culture (less than 24 hours). DFX also suppressed MGC formation in a dose-dependent manner. Using flow cytometry analysis, the co-addition of Fe-citrate significantly suppressed CD18 (beta2 integrin) and CD54 (ICAM-I) but not CD11a (alpha integrin) expression on Con A-stimulated monocytes. Iron supressed the generation of MGC by human monocytes in vitro. These observations suggested that iron might affect MGC generation by down-regulation of adhesion molecule expression on monocytes.
authors: Second Department of Internal Medicine, Kochi Medical School, Nankoku City, Kochi, Japan.
authors: Kiyoshi
authors: K
authors: Tahara
authors: Koji
authors: K
authors: Nishiya
authors: Naoko
authors: N
authors: Hisakawa
authors: Honggang
authors: H
authors: Wang
authors: Kozo
authors: K
authors: Hashimoto
mesh_terms: D000135:Acid Phosphatase / Q000032:analysis; D015703:Antigens, CD / Q000032:analysis; D002459:Cell Fusion; D002478:Cells, Cultured; D002951:Citrates / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005290:Ferric Compounds / Q000494:pharmacology; D015726:Giant Cells / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007501:Iron / Q000494:pharmacology*; D007527:Isoenzymes / Q000032:analysis; D009000:Monocytes / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D000077559:Sodium Citrate; D000071681:Tartrate-Resistant Acid Phosphatase; D013997:Time Factors
chemical_list: D015703:Antigens, CD; D002951:Citrates; D005290:Ferric Compounds; D007527:Isoenzymes; D003208:Concanavalin A; D018799:Intercellular Adhesion Molecule-1; D000077559:Sodium Citrate; C025314:ferric citrate; D007501:Iron; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D003676:Deferoxamine; D019331:NG-Nitroarginine Methyl Ester